• social information if applicable

Vaccine Availability

Anyone 18 and older is eligible for vaccination with any of the three available COVID vaccines in the United States.

Children ages 5-17 can receive the Pfizer-BioNTech vaccination.


Latest Third Dose Recommendations

The FDA and the CDC authorized third doses of the Pfizer and Moderna COVID vaccines as part of the primary vaccine series for patients who are moderately to severely immunocompromised on August 13, 2021. They made this decision after research studies found that a third dose improved the immune response to the vaccine in some immunocompromised patients. Patients who meet the criteria listed at the link below qualify for a third dose of the vaccine 28 days after their second dose of either Pfizer or Moderna. This dose is considered part of their initial vaccination and is not a booster. Subsequent booster shots are recommended as well.

Additional doses are not recommended as part of the Johnson&Johnson initial series, although booster shots are recommended (see below).


Latest Booster Shot Recommendations

The FDA and the CDC authorized booster shots for all adults ages 18 and older on November 29, 2021. These are recommended particularly in the setting of the discovery of the new Omicron COVID variant.

If you had Pfizer or Moderna for your initial vaccine series, you are eligible for a booster shot 6 months from your last dose of that series. If you are moderately to severely immunocompromised and received a third dose of your primary vaccine series, you are still eligible for a booster shot 6 months after that dose.

If you had Johnson&Johnson, you are eligible for a booster shot 2 months after that dose.

You can receive any available vaccine – Pfizer, Moderna, or Johnson&Johnson – for your booster shot.


Questions and Honest Answers About COVID-19 Vaccine

While the vaccines are publicly praised as our best path out of the pandemic, it's understandable to have questions and concerns about whether it's right for you. This series features questions our doctors frequently hear about the COVID-19 vaccine and their honest answers.


Doses Administered

We have administered more than 181,688 first and second doses of the COVID-19 vaccines to patients and employees.


Telehealth Visits

There’s no need to wait. Find and visit one of our providers in person or online through Emory Connected Care. If you need to visit us in person, extraordinary safety measures are in place to protect you, your family, and our staff – including separate treatment areas for patients with COVID-19.


Visitor Policy

Please check the visitor policy regularly.


COVID-19 Admissions, Discharges, and Deaths

Below is a trend of our total COVID-19 related admissions, discharges, and deaths.

From February 17, 2020, to December 5, 2021, our care teams have:

  • Admitted 17,827 patients
  • Discharged 16,549 patients
  • Unfortunately, had 1,213 patients succumb to COVID-19
  • Achieved a 93% overall survival rate—among the highest seen in globally published data

COVID-19 Admissions, Discharges, & Deaths


Get regular news and health updates sent to you. Sign up for Emory Healthcare's Health Source newsletter.